Comparison · not a ranking
MOTS-c compared with SS-31
MOTS-c and SS-31 are separate catalogue items. They are not interchangeable.A CoA for every lot; each vial carries a printed lot number that matches it. Request yours and we email it within 2 hours. Research use only. Not a medicine.
Last verified 9 Nov 2026. UK prices checked daily.
This page compares MOTS-c and SS-31 by chemical identity. MOTS-c is a 16-residue peptide, while SS-31 is a 4-residue peptide. MOTS-c: C101H152N28O22S2, 2174.6 g/mol, CAS 1627580-64-6. SS-31: C32H49N9O5, 639.8 g/mol, CAS 736992-21-5. By sequence, MOTS-c is Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg and SS-31 is D-Arg-Dmt-Lys-Phe-NH2. In short, their molecular weights differ by about 1534.8 g/mol; their sequences differ in length (16 versus 4 residues); only MOTS-c contains sulfur. Each has its own reference record, which lists the source for every figure above. Sable Peptides, a UK supplier operating since 2019, lists both as lyophilised research material; every vial carries a lot number and a certificate of analysis exists for every lot — request yours at /coa-request and we email it within 2 hours. This intro compares identity only and ranks neither compound. Research use only. Not a medicine. Not for human or veterinary use.
Sources: pubchem.ncbi.nlm.nih.gov · pubchem.ncbi.nlm.nih.gov
MOTS-c and SS-31 are two records in the Sable Peptides catalogue at https://www.sablepeptides.co.uk/versus/mots-c/ss-31. These prices are both Sable catalogue prices. They are not a comparison with another shop. This page does not rank either compound. Each page shows the catalogue price. A market comparison appears only when an exact, current, approved listing for that size is on record. Only a row with the same amount is a like-for-like price.
Research use only. Not a medicine. Not for human or veterinary use. Disclaimer
| Amount | MOTS-c | SS-31 |
|---|---|---|
| 5 mg | £9.85 | £25.99 |
| 10 mg | £13.99 | £18.99 |
Reference facts
| Fact | MOTS-c | SS-31 |
|---|---|---|
| Molecular weight | 2174.6 g/mol | 639.8 g/mol |
| Molecular formula | C101H152N28O22S2 | C32H49N9O5 |
| CAS number | 1627580-64-6 | 736992-21-5 |
| Compound class | peptide | peptide |
Sources: pubchem.ncbi.nlm.nih.gov, pubchem.ncbi.nlm.nih.gov Verified 2026-11-09
- Category
- MOTS-cShort sequences
- SS-31Short sequences
- Research use only
- MOTS-cYes
- SS-31Yes
- Vials
- MOTS-c5
- SS-312
- Record
- MOTS-cmots-c
- SS-31ss-31
Questions this page answers
- How does MOTS-c compare with SS-31?
- Same vial amounts are shown side by side with each catalogue price. Different amounts are not treated as the same price. No effect is compared, and another seller is not compared.
- Which is better?
- This page does not say. It does not rank safety, strength, or effect.
- What is the lowest catalogue price per mg for MOTS-c and SS-31?
- MOTS-c: £0.97/mg on the 40 mg vial (£38.99). SS-31: £1.90/mg on the 10 mg vial (£18.99). Different compounds; this is a catalogue price fact, not a ranking.
- How many vial sizes are listed for each?
- MOTS-c: 5 mg, 10 mg, 20 mg, 30 mg, 40 mg. SS-31: 5 mg, 10 mg.
Both compounds
Related research
In-depth comparison
Sable research note. Updated 2026-10-10. Research use only.
Short answer
MOTS-c and SS-31 (elamipretide) are different compounds. MOTS-c is a mitochondrial-derived peptide; SS-31 (elamipretide) is a synthetic tetrapeptide (Szeto-Schiller family). By PubChem's computed values, MOTS-c (2174.6 g/mol) is about 3.4 times the mass of SS-31 (elamipretide) (639.8 g/mol). Sable lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.
At a glance
| MOTS-c | SS-31 (elamipretide) | |
|---|---|---|
| Class | mitochondrial-derived peptide | synthetic tetrapeptide (Szeto-Schiller family) |
| Formula (PubChem) | C101H152N28O22S2 | C32H49N9O5 |
| Molecular weight (PubChem, g/mol) | 2174.6 | 639.8 |
| PubChem CID | 146675088 | 11764719 |
| Sable form | freeze-dried powder | freeze-dried powder |
Structure
MOTS-c is a 16-residue peptide (MRWQEMGYIFYPRKLR) encoded by a short open reading frame within the mitochondrial 12S rRNA gene. PubChem CID 146675088 lists the formula C101H152N28O22S2 and a computed molecular weight of 2174.6 g/mol (https://pubchem.ncbi.nlm.nih.gov/compound/146675088).
SS-31 (elamipretide) is a cationic, aromatic tetrapeptide, D-Arg-Dmt-Lys-Phe-NH2, where Dmt is 2',6'-dimethyltyrosine. PubChem CID 11764719 lists the formula C32H49N9O5 and a computed molecular weight of 639.8 g/mol (https://pubchem.ncbi.nlm.nih.gov/compound/11764719).
Both are peptides, so the meaningful structural differences are sequence, length and modifications rather than chemical category. Differences in residue count, terminal capping (acetylation or amidation), non-natural amino acids and lipid side chains all change molecular weight, solubility and how a compound behaves in an assay. Matching like with like at the structural level is the first step before any comparison of experimental results.
Molecular weight in context
On PubChem's computed figures, MOTS-c is a mid-sized peptide (1,000 to 3,000 g/mol) and SS-31 (elamipretide) is a small molecule-sized compound (under 1,000 g/mol). The difference is 1,534.8 g/mol.
Molecular weight matters in practice for three reasons. First, one milligram of a lighter compound contains more molecules than one milligram of a heavier one, so equal milligram amounts are not equal molar amounts. Second, the expected mass is what identity testing checks against: mass spectrometry on a certificate of analysis should report a value consistent with the formula. Third, salt forms (for example acetate or TFA counter-ions) and metal complexes add mass that a free-base figure does not show, so a certificate may legitimately quote a slightly different value from a database entry.
Class and research context
MOTS-c: described in the literature as a mitochondrial-derived peptide investigated in cellular metabolism research.
SS-31 (elamipretide): described in the literature as a mitochondria-targeted peptide that associates with cardiolipin in the inner membrane.
These descriptions summarise how each compound is characterised in the published literature and in chemical databases. They are not claims about effects in people, and Sable gives no administration or medical-use information for either compound. Readers who need mechanism detail should go to the primary sources and the PubChem literature sections linked below.
How to compare them fairly
- Compare identity first: formula, sequence and expected mass, then purity.
- Compare amounts only at the same milligram size, remembering that equal milligrams are not equal moles.
- Ask for the certificate of analysis for the specific batch. At Sable, every vial is released at ≥99% purity by HPLC with identity checked against the expected mass, and certificates are available for every lot.
- Treat a search pairing as a navigation habit, not as evidence that two compounds do the same thing.
Sable listings
Vial sizes as listed on 2026-10-10. Each product page carries the current catalogue details.
MOTS-c (compound guide: https://www.sablepeptides.co.uk/mots-c-uk): - MOTS-c 5 mg: https://www.sablepeptides.co.uk/product/mots-c-5mg - MOTS-c 10 mg: https://www.sablepeptides.co.uk/product/mots-c-10mg - MOTS-c 20 mg: https://www.sablepeptides.co.uk/product/mots-c-20mg - MOTS-c 40 mg: https://www.sablepeptides.co.uk/product/mots-c-40mg - MOTS-c 30 mg: https://www.sablepeptides.co.uk/product/mots-c-30mg
SS-31 (elamipretide) (compound guide: https://www.sablepeptides.co.uk/ss-31-uk): - SS-31 10 mg: https://www.sablepeptides.co.uk/product/ss-31-10mg - SS-31 5 mg: https://www.sablepeptides.co.uk/product/ss-31-5mg
Peptide vials contain freeze-dried powder only; bacteriostatic water is listed separately. Research use only. Not a medicine. Not for human or veterinary use.
Sources
- PubChem, MOTS-c: https://pubchem.ncbi.nlm.nih.gov/compound/146675088
- PubChem, SS-31 (elamipretide): https://pubchem.ncbi.nlm.nih.gov/compound/11764719
- Sable price index and methodology: https://www.sablepeptides.co.uk/pricing/methodology
- Sable quality and certificate requests: https://www.sablepeptides.co.uk/quality
Comparison questions
What is the difference between MOTS-c and SS-31 (elamipretide)?
MOTS-c and SS-31 (elamipretide) are different compounds. MOTS-c is a mitochondrial-derived peptide; SS-31 (elamipretide) is a synthetic tetrapeptide (Szeto-Schiller family). By PubChem's computed values, MOTS-c (2174.6 g/mol) is about 3.4 times the mass of SS-31 (elamipretide) (639.8 g/mol). Sable lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.
What are the molecular weights of MOTS-c and SS-31 (elamipretide)?
MOTS-c: 2174.6 g/mol (PubChem CID 146675088); SS-31 (elamipretide): 639.8 g/mol (PubChem CID 11764719).
Are these sold for use in people?
No. Both are laboratory research material only: not medicines, and not for use in people or animals. No administration or medical-use information is provided.